Critical Care & Emergencies (all articles) | Page 124 of 187 | Links Medicus Content Curation & Alerts in Medicine

Video: New York City Coronavirus (COVID-19) Update

14 Apr, 2020 | 03:03h | UTC

New York City Coronavirus (COVID-19) Update – JAMA

Ethics in the Time of Coronavirus: Recommendations in the COVID-19 Pandemic

14 Apr, 2020 | 03:00h | UTC

Ethics in the Time of Coronavirus: Recommendations in the COVID-19 Pandemic – Journal of the American College of Surgeons

Commentary on the New IDSA’s COVID-19 Treatment Guidelines

14 Apr, 2020 | 02:49h | UTC

IDSA’s COVID-19 Treatment Guidelines Highlight Difficulty of “Don’t Just Do Something, Stand There” – HIV and ID Observations Blog

See Original Guideline: Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

IDSA Guidelines on the Treatment and Management of Patients with COVID-19 Infection

13 Apr, 2020 | 00:27h | UTC

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection

Related Commentary on Twitter

NEW: IDSA Guidelines on the Treatment & Management of Patients with COVID-19 Infection. These evidence-based rapid guidelines, updated in real-time, will address pressing clinical questions related to caring for patients w/ COVID-19: https://t.co/mvi9Paa8Xv #COVID19Guidelines pic.twitter.com/NKbYAbO21J

— IDSA (@IDSAInfo) April 11, 2020

Compassionate Use of Remdesivir for Patients with Severe Covid-19

13 Apr, 2020 | 00:23h | UTC

Compassionate Use of Remdesivir for Patients with Severe Covid-19 – New England Journal of Medicine

Commentaries: PulmCrit – Eleven reasons the NEJM paper on remdesivir reveals nothing AND Expert reaction to a study about compassionate use of remdesivir for patients with severe COVID-19 – Science Media Centre AND What Do the New Remdesivir Data Mean? – Science Translational Medicine

Study: Neurologic Manifestations Common in Hospitalized Patients with Covid-19

13 Apr, 2020 | 00:25h | UTC

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China – JAMA Neurology

Editorial: The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines

Commentaries: 40% of people with severe COVID-19 experience neurological complications – UPI AND AND Expert reaction to paper on neurological manifestations of patients hospitalised with COVID-19 in Wuhan, China – Science Media Centre

Possible Algorithm to Empiric Anticoagulation in COVID-19 Based on D-Dimer

13 Apr, 2020 | 00:20h | UTC

D-dimer cutoffs to predict thrombosis in COVID-19 – PulmCrit

Note: this link is not an endorsement of the algorithm.

Incidence of Thrombotic Complications in Critically ill ICU Patients with COVID-19

13 Apr, 2020 | 00:22h | UTC

Incidence of thrombotic complications in critically ill ICU patients with COVID-19 – Thrombosis Research

Studies: Obesity Increases the Risk of Complications in Patients with Covid-19

13 Apr, 2020 | 00:14h | UTC

1 – High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation – Obesity

2 – Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission – Clinical Infectious Diseases AND Commentary: In New York, obesity appears to raise COVID-19 risk – CIDRAP

Mechanical Ventilators Adapted from BiPAP machines?

13 Apr, 2020 | 00:17h | UTC

See instructions and protocols developed by Mount Sinai Health System: Repurposing bi-level ventilators for use with intubated patients while minimizing risk to health care works during insufficient supply of conventional ventilation for patients with COVID-19

We want to learn more about this interesting initiative!

Studies: Diabetes Increases the Risk of Complications in Patients with Covid-19

13 Apr, 2020 | 00:12h | UTC

1 – Prevalence and impact of diabetes among people infected with SARS-CoV-2 – Journal of Endocrinological Investigation AND Commentary: Diabetes Could Increase Severity of COVID-19, Including Risk of ICU Admission and Death – MedicalResearch.com

2 – Evidence Reviews: Diabetes and risks from COVID-19 – CEBM University of Oxford AND Managing diabetes during the COVID-19 pandemic – CEBM University of Oxford

[Preprint] Factors Associated with Worse Outcomes Among 4,103 Patients with COVID-19 in New York City

13 Apr, 2020 | 00:09h | UTC

Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City – medRxiv

Updated Guidance on Personal Protective Equipment (PPE) for Clinicians

13 Apr, 2020 | 00:02h | UTC

Updated guidance on Personal Protective Equipment (PPE) for clinicians – Intensive Care Society

COVID-19 Testing: The Threat of False-Negative Results

13 Apr, 2020 | 00:04h | UTC

COVID-19 Testing: The Threat of False-Negative Results – Mayo Clinic Proceedings

Commentary: False-negative COVID-19 test results may lead to false sense of security – Mayo Clinic

New Clinical Score: Prediction for Progression Risk in Patients with COVID-19 Pneumonia

12 Apr, 2020 | 23:58h | UTC

Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score – Clinical Infectious Diseases

Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score – Comorbidity; older Age; Lower lymphocyte; and higher Lactate dehydrogenase at presentation were independent high-risk factors for COVID-19 progression. (via @veselov78 see Tweet)

NICE Publishes new COVID-19 Guidelines on Cystic Fibrosis, COPD and Dermatological Conditions

10 Apr, 2020 | 03:22h | UTC

News Release: NICE publishes new COVID-19 guidelines on cystic fibrosis, chronic obstructive pulmonary disease (COPD) and dermatological conditions – National Institute for Health and Care Excellence

See New COVID-19 Rapid Guidelines: Community-based care of patients with chronic obstructive pulmonary disease (COPD) AND Cystic fibrosis AND Dermatological conditions treated with drugs affecting the immune response

See Other COVID-19 Rapid Guidelines: Severe asthma AND Managing suspected or confirmed pneumonia in adults in the community AND Rheumatological autoimmune, inflammatory and metabolic bone disorders AND Managing symptoms (including at the end of life) in the community AND Critical care in adults AND Hematopoietic stem cell transplantation AND Dialysis service delivery AND Delivery of radiotherapy AND Delivery of systemic anticancer treatments

AHA Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates with Suspected or Confirmed COVID-19

10 Apr, 2020 | 03:20h | UTC

Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With the Guidelines®-Resuscitation Adult and Pediatric Task Forces of the American Heart Association in Collaboration with the American Academy of Pediatrics, American Association for Respiratory Care, American College of Emergency Physicians, The Society of Critical Care Anesthesiologists, and American Society of Anesthesiologists: Supporting Organizations: American Association of Critical Care Nurses and National EMS Physicians – Circulation

News Release: Interim CPR guidelines address challenges of providing resuscitation during COVID-19 pandemic – American Heart Association

Related Commentary on Twitter

The AHA, with several other health care organizations, has compiled interim guidance to help rescuers treat victims of cardiac arrest with suspected or confirmed #COVID19. Healthcare workers are the highest risk group for contracting COVID-19. Learn more: https://t.co/0HFeIJGoSS pic.twitter.com/EE4KxaM9BC

— AHA Science (@AHAScience) April 9, 2020